GF Ingrassia Hospital
Palermo, 90100, Italy
NCT Number: NCT01156337
The study was aimed to verify the effects of Hypertonic saline solution (HSS) and a moderate sodium (Na) restriction plus high furosemide dose in the short term (hospitalization time) and a moderate Na restriction in the long term on readmissions and mortality in patients in III NYHA class.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Palermo, 90100, Italy
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Looking for future studies?
Notify MeOspedale G. F. Ingrassia
Other
Sodium Management in Acute and Chronic Phases in Patients With New York Heart Association Class III (Class C) Heart Failure. Short and Long Term Findings.
Acronym: SMAC-HF
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07833384
Arterial Occlusive Diseases, Arteriosclerosis
Baton Rouge, Louisiana, United States
View Trial DetailsNCT04591639
Cardiomyopathies, Cardiovascular Diseases
Edinburgh, Scotland, United Kingdom
View Trial DetailsNCT05696522
Arrhythmias, Cardiac, Cardiac Conduction System Disease
London, United Kingdom
View Trial DetailsNCT07390110
Cardiovascular Diseases, Diabetes Mellitus
Boston, Massachusetts, United States
View Trial Details